Relmada Therapeutics, Inc.
RLMD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001553643
In the last 90 days, Relmada Therapeutics, Inc. insiders filed 2 open-market purchases and 0 sales; 126 institutions reported holding it in 13F filings for Q2 2026, worth $693.7M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Relmada Therapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 97
- +12 vs. Q3 2021
- Shares held
- 20.7M
- +10.7M (+107.6%) vs. Q3 2021
- Total value
- $467.2M
- +$205.3M (+78.4%) vs. Q3 2021
- New holders
- 28
- 27 more added
- Sold out
- 16
- 24 more reduced
2 institutions that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RLMD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 126 | $693.7M |
| Q1 2026 | 103 | $588.8M |
| Q4 2025 | 78 | $245.8M |
| Q3 2025 | 44 | $15.5M |
| Q2 2025 | 50 | $3.18M |
| Q1 2025 | 44 | $1.68M |
| Q4 2024 | 48 | $4.36M |
| Q3 2024 | 69 | $40.2M |
| Q2 2024 | 79 | $40.7M |
| Q1 2024 | 93 | $66.5M |
| Q4 2023 | 83 | $56.4M |
| Q3 2023 | 88 | $45.0M |
| Q2 2023 | 95 | $39.7M |
| Q1 2023 | 91 | $40.3M |
| Q4 2022 | 110 | $66.8M |
| Q3 2022 | 134 | $953.6M |
| Q2 2022 | 113 | $468.5M |
| Q1 2022 | 113 | $623.1M |
| Q4 2021 | 97 | $467.2M |
| Q3 2021 | 87 | $262.8M |
| Q2 2021 | 85 | $318.3M |
| Q1 2021 | 82 | $335.7M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Relmada Therapeutics, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| State of Wisconsin Investment Board | 0 | $0 | 0.00% | −20,100−100.0% | Sold out |
| Parametric Portfolio Associates LLC | 0 | $0 | 0.00% | −18,117−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −16,900−100.0% | Sold out |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −10,699−100.0% | Sold out |
| Manufacturers Life Insurance Company, The | 0 | $0 | 0.00% | −8,407−100.0% | Sold out |
| Price T Rowe Associates Inc | 0 | $0 | 0.00% | −8,057−100.0% | Sold out |
| DekaBank Deutsche Girozentrale | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −2,035−100.0% | Sold out |
| Penserra Capital Management LLC | 0 | $0 | 0.00% | −400−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −184−100.0% | Sold out |
| Glen Eagle Advisors, LLC | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| Retirement Group, LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Spotlight Asset Group, Inc. | – | – | – | – | Not filed |
| Knott David M | – | – | – | – | Not filed |